Moses D. Lugos

1.4k total citations
31 papers, 1.1k citations indexed

About

Moses D. Lugos is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Moses D. Lugos has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 17 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Moses D. Lugos's work include Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (15 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Moses D. Lugos is often cited by papers focused on Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (15 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Moses D. Lugos collaborates with scholars based in Gambia, United Kingdom and Nigeria. Moses D. Lugos's co-authors include Philip C. Hill, Richard A. Adegbola, Simon Donkor, Roger H. Brookes, Annette Fox, David Jeffries, Dolly Jackson-Sillah, Keith P. W. J. McAdam, Abdulrahman S. Hammond and Ifedayo Adetifa and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and PEDIATRICS.

In The Last Decade

Moses D. Lugos

30 papers receiving 1.1k citations

Peers

Moses D. Lugos
Jackson Sillah United Kingdom
Moses D. Lugos
Citations per year, relative to Moses D. Lugos Moses D. Lugos (= 1×) peers Jackson Sillah

Countries citing papers authored by Moses D. Lugos

Since Specialization
Citations

This map shows the geographic impact of Moses D. Lugos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moses D. Lugos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moses D. Lugos more than expected).

Fields of papers citing papers by Moses D. Lugos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moses D. Lugos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moses D. Lugos. The network helps show where Moses D. Lugos may publish in the future.

Co-authorship network of co-authors of Moses D. Lugos

This figure shows the co-authorship network connecting the top 25 collaborators of Moses D. Lugos. A scholar is included among the top collaborators of Moses D. Lugos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moses D. Lugos. Moses D. Lugos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kerry, Rout George, Priyanka Mohapatra, Atala Bihari Jena, et al.. (2022). Biosynthesis of Rutin Trihydrate Loaded Silica Nanoparticles and Investigation of Its Antioxidant, Antidiabetic and Cytotoxic Potentials. Journal of Inorganic and Organometallic Polymers and Materials. 32(6). 2065–2081. 3 indexed citations
4.
Adetifa, Ifedayo, Lindsay Kendall, Simon Donkor, et al.. (2017). Mycobacterium tuberculosis Infection in Close Childhood Contacts of Adults with Pulmonary Tuberculosis is Increased by Secondhand Exposure to Tobacco. American Journal of Tropical Medicine and Hygiene. 97(2). 429–432. 9 indexed citations
5.
Lugos, Moses D., et al.. (2015). Malaria Parasitemia in Apparently Healthy Blood Donors in North-Central Nigeria. Laboratory Medicine. 46(1). 42–46. 5 indexed citations
6.
Adetifa, Ifedayo, Martin O. C. Ota, David Jeffries, et al.. (2012). Interferon-γ ELISPOT as a Biomarker of Treatment Efficacy in Latent Tuberculosis Infection. American Journal of Respiratory and Critical Care Medicine. 187(4). 439–445. 44 indexed citations
7.
Adetifa, Ifedayo, Martin O. C. Ota, David Jeffries, et al.. (2010). Commercial Interferon Gamma Release Assays Compared to the Tuberculin Skin Test for Diagnosis of Latent Mycobacterium tuberculosis Infection in Childhood Contacts in the Gambia. The Pediatric Infectious Disease Journal. 29(5). 439–443. 43 indexed citations
8.
Adetifa, Ifedayo, Martin O. C. Ota, Brigitte Walther, et al.. (2010). Decay Kinetics of an Interferon Gamma Release Assay with Anti-Tuberculosis Therapy in Newly Diagnosed Tuberculosis Cases. PLoS ONE. 5(9). e12502–e12502. 32 indexed citations
9.
Lugos, Moses D., Ifedayo Adetifa, Simon Donkor, et al.. (2009). Evaluation of the Contribution of Major T Cell Subsets to IFN-γ Production in TB Infection by ELISPOT. Immunological Investigations. 38(5). 341–349. 4 indexed citations
10.
Hill, Philip C., Dolly Jackson-Sillah, Annette Fox, et al.. (2008). Incidence of Tuberculosis and the Predictive Value of ELISPOT and Mantoux Tests in Gambian Case Contacts. PLoS ONE. 3(1). e1379–e1379. 101 indexed citations
11.
Hill, Philip C., David Jeffries, Roger H. Brookes, et al.. (2007). Using ELISPOT to Expose False Positive Skin Test Conversion in Tuberculosis Contacts. PLoS ONE. 2(1). e183–e183. 31 indexed citations
12.
Lugos, Moses D., Abdulrahman S. Hammond, David Jeffries, et al.. (2007). Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infectious Diseases. 7(1). 122–122. 69 indexed citations
13.
Fox, Annette, David Jeffries, Philip C. Hill, et al.. (2007). ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease. Transactions of the Royal Society of Tropical Medicine and Hygiene. 101(7). 691–698. 12 indexed citations
14.
Jackson-Sillah, Dolly, Philip C. Hill, Annette Fox, et al.. (2007). Screening for tuberculosis among 2381 household contacts of sputum-smear-positive cases in The Gambia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 101(6). 594–601. 35 indexed citations
15.
Burl, Sarah, Philip C. Hill, David Jeffries, et al.. (2007). FOXP3 gene expression in a tuberculosis case contact study. Clinical & Experimental Immunology. 149(1). 117–122. 40 indexed citations
16.
Hill, Philip C., Roger H. Brookes, Annette Fox, et al.. (2007). Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection. PLoS Medicine. 4(6). e192–e192. 139 indexed citations
17.
Hill, Philip C., Roger H. Brookes, Annette Fox, et al.. (2006). Surprisingly High Specificity of the PPD Skin Test for M. tuberculosis Infection from Recent Exposure in The Gambia. PLoS ONE. 1(1). e68–e68. 18 indexed citations
18.
Aiken, Alexander M., Philip C. Hill, Annette Fox, et al.. (2006). Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infectious Diseases. 6(1). 66–66. 107 indexed citations
19.
Hill, Philip C., Annette Fox, David Jeffries, et al.. (2004). Quantitative T Cell Assay Reflects Infectious Load of Mycobacterium tuberculosis in an Endemic Case Contact Model. Clinical Infectious Diseases. 40(2). 273–278. 60 indexed citations
20.
Hill, Philip C., Roger H. Brookes, Annette Fox, et al.. (2004). Large‐Scale Evaluation of Enzyme‐Linked Immunospot Assay and Skin Test for Diagnosis ofMycobacterium tuberculosisInfection against a Gradient of Exposure in The Gambia. Clinical Infectious Diseases. 38(7). 966–973. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026